Georgia Champion Takes Top Honor at Prestigious International BioGENEius Challenge

Milton High School Senior  Shreya Ramesh  Achieves Global Excellence in Scientific Research

ATLANTA–( BUSINESS WIRE )–Shreya Ramesh, a Milton High School senior, from Milton, Georgia, and local winner of the Georgia BioGENEius Challenge, has taken the top prize at the fiercely competitive International BioGENEius Challenge. Shreya’s innovative work on voice recognition data and Amyotrophic Lateral Sclerosis (ALS) stood out among her fellow finalists.

“We just couldn’t be more ecstatic—for Shreya as well as for the future of all biotech innovation,” said Georgia Bio President and CEO Maria Thacker. “We knew how talented she was when we saw her work, but the fact that our local winner’s unbelievably sophisticated research won the top prize at this advanced level shows you just what we can do in biotech here in Georgia, not to mention how brilliant and innovative Georgia students are.”

Organized by the Biotechnology Institute, the annual competition brings together young innovators from across North America and Germany to compete before an accomplished panel of established biotechnology researchers and academics. The winner walks away with the recognition, advisement, and support of some of the world’s best biotech innovators as well $7,500 in prize money.

Shreya’s research topic focused on the problem of Amyotrophic Lateral Sclerosis (ALS) patients, many of whom rely on Automatic Speech Recognition (ASR) tools such as Google Voice, with voice characteristics that can unfortunately be unreadable to ARS programs. As a result of the condition, the voices of ALS patients can be slow and high pitched, making ARS software interaction problematic. Shreya’s solution was to create a novel voice compensation algorithm that converted an ALS patient’s unique vocal texture into one more easily recognized by the programs.

“Winning the BioGENEius Challenge feels absolutely amazing,” said Shreya Ramesh. “It’s great to know that my project has the potential to change lives and that I’ll have a supportive platform to help me do that. The competition was the  best  experience—I’ve met so many students who are just as passionate as I am about using biotech to change the world!”

Judges of the 2020 International BioGENEius Challenge included BioEd Institute Board Member and past Chair, Jamie Graham, partner at Kilpatrick Townsend & Stockton, to whom Georgia Bio and the Georgia BioEd Institute offer a special thanks.

About the Biotechnology Institute

The Biotechnology Institute is an independent, national nonprofit organization dedicated to education about the present and future impact of biotechnology. Its mission is to engage, excite and educate the public, particularly students and teachers, about biotechnology and its immense potential for solving human health, food and environmental problems. For more information, visit  www.biotechinstitute.org.

About the Georgia BioEd Institute 

The Georgia BioEd Institute is a division of Georgia Bio, a 501(c)(3) nonprofit organization serving the state’s life science industry. The Institute’s mission is to strengthen Georgia’s life sciences workforce pipeline through classroom-to-career initiatives that align with industry needs. Learn more at  www.georgiabioed.org  |  www.gabio.org.

March 17, 2026
Georgia Life Sciences leads effort to establish bipartisan caucus focused on advancing the state’s growing life sciences economy
March 13, 2026
A skilled workforce is the engine that will drive growth across America’s biotechnology industry, and Atlanta has built multi-faceted training programs that are developing and sustaining the talent pipeline for everything from advanced laboratory research to industrial biomanufacturing.
March 12, 2026
On March 12, 2026, Augusta, Georgia served as the setting for an important conversation about the future of American biotechnology and manufacturing. Manus welcomed members of the U.S. National Security Commission on Emerging Biotechnology (NSCEB) to its Augusta BioFacility to highlight how advanced biomanufacturing is strengthening U.S. supply chain resilience and supporting the growing bioeconomy. During the visit, Manus unveiled a significant expansion of its 44-acre Augusta BioFacility, increasing domestic capacity to produce critical biobased ingredients. The expansion further positions Georgia as a key hub for advanced biomanufacturing and demonstrates the growing role of biotechnology in strengthening national economic and supply chain security. Commission members met with leaders from industry, government, and academia to discuss strategies for scaling manufacturing infrastructure, strengthening resilient supply chains, and preparing the workforce needed to support the next generation of the U.S. bioeconomy. The visit also included conversations with Manus employees about the practical realities of building and operating advanced biomanufacturing facilities in the United States. The Augusta site has become one of the largest advanced biomanufacturing facilities in the country, producing a growing portfolio of bioalternatives at industrial scale. Among these products is high-purity Reb M, recently launched as Yume™ M Stevia Sweetener , supported by an all-Americas supply chain. “As we scale the Manus bioalternatives platform, Augusta has become a powerful example of what the modern U.S. bioeconomy looks like in practice,” said Manus Founder and CEO Ajikumar Parayil. The visit underscores Georgia’s expanding leadership in life sciences manufacturing and highlights how regional ecosystems can help advance U.S. leadership in biotechnology and biomanufacturing. Learn more about the expansion and visit: Manus welcomes U.S. National Security Commission on Emerging Biotechnology to unveil major Augusta BioFacility expansion Growing Georgia Biomanufacturing Industry Transforming American Industrial Strength
MORE POSTS